FI934680A0 - Arylmorfolin, framstaellning och anvaending - Google Patents
Arylmorfolin, framstaellning och anvaendingInfo
- Publication number
- FI934680A0 FI934680A0 FI934680A FI934680A FI934680A0 FI 934680 A0 FI934680 A0 FI 934680A0 FI 934680 A FI934680 A FI 934680A FI 934680 A FI934680 A FI 934680A FI 934680 A0 FI934680 A0 FI 934680A0
- Authority
- FI
- Finland
- Prior art keywords
- arylmorfolin
- anvaending
- framstaellning och
- human
- framstaellning
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Photoreceptors In Electrophotography (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919108629A GB9108629D0 (en) | 1991-04-23 | 1991-04-23 | Heterocyclic pharmaceutical compounds,preparation and use |
PCT/GB1992/000733 WO1992018489A1 (en) | 1991-04-23 | 1992-04-22 | Arylmorpholine, preparation and use |
Publications (2)
Publication Number | Publication Date |
---|---|
FI934680A FI934680A (fi) | 1993-10-22 |
FI934680A0 true FI934680A0 (fi) | 1993-10-22 |
Family
ID=10693740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI934680A FI934680A0 (fi) | 1991-04-23 | 1993-10-22 | Arylmorfolin, framstaellning och anvaending |
Country Status (17)
Country | Link |
---|---|
US (2) | US5648347A (fi) |
EP (1) | EP0583271B1 (fi) |
JP (1) | JP3130040B2 (fi) |
AT (1) | ATE173252T1 (fi) |
AU (1) | AU668863B2 (fi) |
CA (1) | CA2108967C (fi) |
DE (1) | DE69227583T2 (fi) |
DK (1) | DK0583271T3 (fi) |
ES (1) | ES2124256T3 (fi) |
FI (1) | FI934680A0 (fi) |
GB (1) | GB9108629D0 (fi) |
HU (1) | HU219458B (fi) |
IE (1) | IE921260A1 (fi) |
NZ (1) | NZ242421A (fi) |
PT (1) | PT100415B (fi) |
WO (1) | WO1992018489A1 (fi) |
ZA (1) | ZA922910B (fi) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9108629D0 (en) * | 1991-04-23 | 1991-06-12 | Wellcome Found | Heterocyclic pharmaceutical compounds,preparation and use |
ATE365042T1 (de) | 1998-01-21 | 2007-07-15 | Glaxo Group Ltd | Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen |
US7098206B2 (en) | 1998-01-21 | 2006-08-29 | Smithkline Beecham Corporation | Pharmaceutically active morpholinol |
US6998400B2 (en) | 1998-01-22 | 2006-02-14 | Smithkline Beecham Corporation | Pharmaceutically active morpholinol |
US6855820B2 (en) * | 1999-01-20 | 2005-02-15 | Smithkline Beecham Corporation | Pharmaceutically active morpholinol |
US6734213B2 (en) | 1999-01-20 | 2004-05-11 | Smithkline Beecham Corporation | Pharmaceutically active morpholinol |
FR2796069B3 (fr) * | 1999-07-09 | 2001-08-24 | Sanofi Synthelabo | Nouveaux procedes de preparation de derives de 2-(2- arylmorpholin-2-yl)ethanol substitues, enantiomeriquement purs, et composes intermediaires utiles dans ces procedes |
RS51442B (en) * | 2002-12-10 | 2011-04-30 | Pfizer Inc. | MORPHOLINE DERIVATIVES USED AS DOPAMINE AGONISTS IN TREATMENT I.A. SEXUAL DYSFUNCTIONS |
US7323462B2 (en) | 2002-12-10 | 2008-01-29 | Pfizer Inc. | Morpholine dopamine agonists |
GB0228787D0 (en) * | 2002-12-10 | 2003-01-15 | Pfizer Ltd | Morpholine dopamine agonists |
CA2800220C (en) * | 2010-05-21 | 2019-04-30 | Research Triangle Institute | Phenylmorpholines and analogues thereof |
JP5952267B2 (ja) | 2010-05-21 | 2016-07-13 | リサーチ・トライアングル・インスティチュート | 薬物依存を処置するためのヒドロキシブプロピオン類似体(政府支援研究または開発) |
CN105949142B (zh) * | 2016-05-21 | 2018-03-27 | 南华大学 | 具有抗抑郁活性的单一手性化合物及其制备方法和应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2997469A (en) * | 1961-08-22 | Preparation of substituted | ||
GB851311A (en) * | 1958-04-02 | 1960-10-12 | Geigy Ag J R | Morpholine compounds and their production |
US3117967A (en) * | 1962-04-02 | 1964-01-14 | Smith Kline French Lab | 2-biphenylyl-2-hydroxy-morpholinium halides |
GB1336732A (en) * | 1970-10-28 | 1973-11-07 | Istituto Gentili Spa Pisa | Diethanolamine derivatives |
IE50355B1 (en) * | 1979-10-20 | 1986-04-02 | Wyeth John & Brother Ltd | Morpholine derivatives |
FR2517305B1 (fr) * | 1981-12-01 | 1985-10-25 | Lafon Labor | Nouveaux derives de 2-phenyl-morpholine et leur utilisation en therapeutique |
FR2553410B1 (fr) * | 1983-10-14 | 1986-05-16 | Lafon Labor | Nouveaux derives de 2-tolyl-morpholine utiles en therapeutique |
FR2553411B1 (fr) * | 1983-10-14 | 1986-08-01 | Lafon Labor | Derives de 2-halogenophenyl-morpholine, procede de preparation et utilisation en therapeutique |
FR2553413B1 (fr) * | 1983-10-17 | 1986-03-21 | Lafon Labor | Derives de 4-alkyl-2-hydroxy-3-methyl-2-phenyl-morpholine, procede de preparation et utilisation en therapeutique |
GB8417170D0 (en) * | 1984-07-05 | 1984-08-08 | Wellcome Found | Heterocyclic pharmaceutical compounds |
US4803200A (en) * | 1987-10-02 | 1989-02-07 | A. H. Robins Company, Incorporated | Substituted dialkanolamines, sulfur analogs and condensed 1,4-oxazine derivatives thereof in viral disease treatment |
GB8924528D0 (en) * | 1989-10-31 | 1989-12-20 | Wellcome Found | Heterocyclic pharmaceutical compounds,preparation and use |
GB9108629D0 (en) * | 1991-04-23 | 1991-06-12 | Wellcome Found | Heterocyclic pharmaceutical compounds,preparation and use |
-
1991
- 1991-04-23 GB GB919108629A patent/GB9108629D0/en active Pending
-
1992
- 1992-04-22 CA CA002108967A patent/CA2108967C/en not_active Expired - Fee Related
- 1992-04-22 JP JP04508053A patent/JP3130040B2/ja not_active Expired - Fee Related
- 1992-04-22 WO PCT/GB1992/000733 patent/WO1992018489A1/en active IP Right Grant
- 1992-04-22 NZ NZ242421A patent/NZ242421A/en unknown
- 1992-04-22 DK DK92908819T patent/DK0583271T3/da active
- 1992-04-22 IE IE126092A patent/IE921260A1/en not_active IP Right Cessation
- 1992-04-22 DE DE69227583T patent/DE69227583T2/de not_active Expired - Fee Related
- 1992-04-22 PT PT100415A patent/PT100415B/pt not_active IP Right Cessation
- 1992-04-22 AU AU15753/92A patent/AU668863B2/en not_active Ceased
- 1992-04-22 AT AT92908819T patent/ATE173252T1/de not_active IP Right Cessation
- 1992-04-22 ZA ZA922910A patent/ZA922910B/xx unknown
- 1992-04-22 EP EP92908819A patent/EP0583271B1/en not_active Expired - Lifetime
- 1992-04-22 HU HU9303000A patent/HU219458B/hu not_active IP Right Cessation
- 1992-04-22 ES ES92908819T patent/ES2124256T3/es not_active Expired - Lifetime
-
1993
- 1993-10-22 FI FI934680A patent/FI934680A0/fi not_active IP Right Cessation
-
1995
- 1995-05-19 US US08/444,609 patent/US5648347A/en not_active Expired - Fee Related
-
1997
- 1997-03-28 US US08/828,935 patent/US5760224A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FI934680A (fi) | 1993-10-22 |
US5648347A (en) | 1997-07-15 |
CA2108967C (en) | 2002-10-08 |
DE69227583T2 (de) | 1999-04-01 |
EP0583271B1 (en) | 1998-11-11 |
ATE173252T1 (de) | 1998-11-15 |
HUT70531A (en) | 1995-10-30 |
NZ242421A (en) | 1994-10-26 |
AU1575392A (en) | 1992-11-17 |
PT100415A (pt) | 1993-06-30 |
ES2124256T3 (es) | 1999-02-01 |
IE921260A1 (en) | 1992-11-04 |
JPH06506675A (ja) | 1994-07-28 |
DK0583271T3 (da) | 1999-07-26 |
HU219458B (hu) | 2001-04-28 |
GB9108629D0 (en) | 1991-06-12 |
HU9303000D0 (en) | 1994-01-28 |
CA2108967A1 (en) | 1992-10-24 |
PT100415B (pt) | 1999-08-31 |
ZA922910B (en) | 1994-01-24 |
AU668863B2 (en) | 1996-05-23 |
WO1992018489A1 (en) | 1992-10-29 |
JP3130040B2 (ja) | 2001-01-31 |
EP0583271A1 (en) | 1994-02-23 |
DE69227583D1 (de) | 1998-12-17 |
US5760224A (en) | 1998-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9504661D0 (sv) | New compounds | |
MY132705A (en) | Novel compounds with analgesic effect | |
ES2141957T3 (es) | Uso de raloxifeno y sus analogos para la produccion de un medicamento para el tratamiento de enfermedades virales. | |
DE69727956D1 (de) | Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen | |
FI934680A0 (fi) | Arylmorfolin, framstaellning och anvaending | |
RU94045271A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера | |
SE9504662D0 (sv) | New compounds | |
EA199700136A1 (ru) | Способы ингибирования экзогенных эстрогенов | |
ES2104938T3 (es) | Metodo de inhibir la fibrosis. | |
DE69430074D1 (de) | Analgetische 4-arylisoindolen | |
NO950177D0 (no) | Farmakologisk aktive erivater | |
SE9603284D0 (sv) | New compounds | |
DK0772438T3 (da) | Anvendelse af benzothiophener til fremstilling af et medikament til reduktion af ardannelse under sårheling | |
MX9709536A (es) | Metodo para reducir el factor de transcripcion bef-1. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired |